The first stop for professional medicines advice

COVID-19 Treatments

10 results

RelevanceNewest firstOldest firstTitle
Applied filters

Preparing Casirivimab 600mg Imdevimab 600mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 600mg Imdevimab 600mg using 11.1mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 11.1mL Vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are pregnant

12 October 2021A careful risk assessment should be done on the benefits of this off-label use to the mother, and the risks it poses to the fetus or neonate.

Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are breastfeeding

12 October 2021Tocilizumab and sarilumab can be used off-label to treat hospitalised patients with COVID-19. Breastfeeding can continue if these treatments are required.

Handling casirivimab and imdevimab within Trusts

17 September 2021An outline process and supporting materials to help Trusts deploy Ronapreve

Using casirivimab and imdevimab pandemic packs

17 September 2021Initial supplies of casirivimab and imdevimab will be pandemic packs supplied under a Batch Specific Variation to the conditional marketing authorisation

COVID-19 neutralising monoclonal antibodies and SPS support

17 September 2021Implementation of effective process control is essential to ensure that neutralising monoclonal antibody products are implemented safely.

Getting ready to use casirivimab and imdevimab: guidance for Chief Pharmacists

17 September 2021This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of casirivimab and imdevimab in COVID-19 infection.